Table 2.
Phase 1-CTN 032 LRADAC (enrollment) Jan ’09 – May ‘09 |
Phase 2-Pilot Implementation (detox pilot) Sept ‘09 – March ‘10 |
Phase 3-Full Implementation (detox and outpatient) April ’10 – July ‘10 |
|
---|---|---|---|
N=115 | N=184 | N=107 | |
Client Characteristics |
|||
Black | 50% | 49% | 65% |
White | 39% | 45% | 32% |
Mixed | 8% | 1% | 0% |
American Indian/Alaskan Native |
1% | 2% | 0% |
Other | 2% | 2% | 3% |
Hispanic | 3% | 1% | 3% |
Female | 44% | 33% | 34% |
Testing Acceptance |
|||
Test offered | * | 299 | 197 |
Acceptance Rate | * | 184/62% | 107/54% |
Cost | |||
Cost/Compensation to client |
No Cost/$35 compensation for baseline assessment |
No cost/no compensation |
No cost/no compensation |
No comparable data from clinical trial